Intralipid: Difference between revisions
(Created page with "==General== *Type: *Dosage Forms: *Routes of Administration: *Common Trade Names: ==Adult Dosing== ==Pediatric Dosing== ==Special Populations== *Drug Ratings in Pregnan...") |
No edit summary |
||
| Line 1: | Line 1: | ||
==General== | ==General== | ||
*Type: | *Type: Lipid emulsion | ||
*Dosage Forms: | *Dosage Forms: 20% fat emulsion | ||
*Routes of Administration: | *Routes of Administration: IV | ||
*Common Trade Names: | *Common Trade Names: Intralipid | ||
==Adult Dosing== | ==Adult Dosing== | ||
*1.5 ml/kg bolus<ref>Cave, G. Intravenous Lipid Emulsion as Antidote Beyond Local Anesthetic Toxicity: A Systematic Review. 2009. 16(9)815–824</ref> | |||
**Followed by 0.25 ml/kg/min for 20 min or until hemodynamic stability is achieved.<ref>Dillane D, Finucane BT. Local anesthetic systemic toxicity. Can J Anaesth. 2010 Apr;57(4):368-80.</ref> | |||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
==Special Populations== | ==Special Populations== | ||
| Line 26: | Line 29: | ||
===Common=== | ===Common=== | ||
==Pharmacology== | ==Pharmacology== | ||
| Line 32: | Line 36: | ||
*Excretion: | *Excretion: | ||
*Mechanism of Action: | *Mechanism of Action: | ||
==Comments== | ==Comments== | ||
==See Also== | ==See Also== | ||
*[[Beta-blocker toxicity]] | |||
*[[Local Anesthetic Systemic Toxicity (LAST)]] | |||
==References== | ==References== | ||
Revision as of 21:19, 12 August 2015
General
- Type: Lipid emulsion
- Dosage Forms: 20% fat emulsion
- Routes of Administration: IV
- Common Trade Names: Intralipid
Adult Dosing
- 1.5 ml/kg bolus[1]
- Followed by 0.25 ml/kg/min for 20 min or until hemodynamic stability is achieved.[2]
Pediatric Dosing
Special Populations
- Pregnancy Rating:
- Lactation risk:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action:
Comments
See Also